Friday - July 18, 2025
Nanoscope Begins Rolling BLA Submission to FDA for Seeking Approval for Its Optogenetic Therapy
July 15, 2025
COLUMBIA, Maryland, July 15 -- The Foundation Fighting Blindness issued the following news:

* * *

Nanoscope Begins Rolling BLA Submission to FDA for Seeking Approval for its Optogenetic Therapy

The company plans to complete BLA submission in early 2026.

Nanoscope Therapeutics, a developer of therapies for retinal diseases, has submitted the first modules of a Biologics License Application (https://nanostherapeutics.com/2025/07/14/nanoscope-ther . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products